SQUARE IMPRINT (Maxalt-MLT 10 mg)

Generic Name: rizatriptan

Pill imprint SQUARE IMPRINT has been identified as Maxalt-MLT 10 mg.

Maxalt-MLT is used in the treatment of migraine and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Maxalt-MLT 10 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for SQUARE IMPRINT

Maxalt-MLT 10 mg SQUARE IMPRINT
Maxalt-MLT 10 mg SQUARE IMPRINT
Maxalt-MLT
Generic Name:
rizatriptan
Imprint:
SQUARE IMPRINT
Strength:
10 mg
Color:
White
Size:
14.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Antimigraine agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Merck & Company Inc.
National Drug Code (NDC):
00006-3801
Inactive Ingredients:
gelatin
mannitol
glycine
aspartame
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-4499 Physicians Total Care Inc (repackager)
68115-0882 Dispensexpress Inc (repackager)
35356-0275 Lake Erie Medical and Surgical Supply (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web1)